0001341004-15-000278.txt : 20150407 0001341004-15-000278.hdr.sgml : 20150407 20150407162304 ACCESSION NUMBER: 0001341004-15-000278 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20150407 DATE AS OF CHANGE: 20150407 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Platform Specialty Products Corp CENTRAL INDEX KEY: 0001590714 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-87814 FILM NUMBER: 15757013 BUSINESS ADDRESS: STREET 1: 1450 CENTREPARK BLVD STREET 2: SUITE 210 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 BUSINESS PHONE: 561-207-9600 MAIL ADDRESS: STREET 1: 1450 CENTREPARK BLVD STREET 2: SUITE 210 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Permira IV Managers LP CENTRAL INDEX KEY: 0001521239 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: TRAFALGAR COURT CITY: LES BANQUES STATE: Y7 ZIP: Y7 GY1 3QL BUSINESS PHONE: 00 44 1481 745 000 MAIL ADDRESS: STREET 1: TRAFALGAR COURT CITY: LES BANQUES STATE: Y7 ZIP: Y7 GY1 3QL FORMER COMPANY: FORMER CONFORMED NAME: Permira Managers IV L.P. DATE OF NAME CHANGE: 20110519 SC 13G 1 sc13g.htm SCHEDULE 13G sc13g.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G
 
(Rule 13d-102)
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d)
AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2
 
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
(Amendment No. __________)*
 
PLATFORM SPECIALTY PRODUCTS CORPORATION
(Name of Issuer)
 
Common Stock, Par Value $0.01 Per Share
(Title of Class of Securities)
 
72766Q105
(CUSIP Number)
 
February 13, 2015
(Date of Event Which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
o Rule 13d-1(b)
 
x Rule 13d-1(c)
 
¨ Rule 13d-1(d)
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 

 
 

 
 
CUSIP No.  72766Q105
13G
  Page _1__ of __4_ Pages

 
1
NAMES OF REPORTING PERSONS
 
Permira IV Managers L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  o
3
SEC USE ONLY
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Guernsey
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
5
SOLE VOTING POWER
 
0
6
SHARED VOTING POWER
 
22,107,590*
7
SOLE DISPOSITIVE POWER
 
0
8
SHARED DISPOSITIVE POWER
 
22,107,590*
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
22,107,590*
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
10.3%
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
PN

___________________
 
* These shares are currently held in the form of Series B Preferred Stock, convertible at the Reporting Persons’ option; provided, that 19,296,242 shares may not be converted until the earlier of the expiration or early termination of any waiting period under the Hart Scot Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”).
 
The calculation of the foregoing percentage is based on 192,220,472 shares of Common Stock (defined below), outstanding as of March 23, 2015 as reported in the Annual Report on Form 10-K for the fiscal year ended December 31, 2014 of Platform Specialty Products Corporation as filed on March 30, 2015.
 

 
 

 

CUSIP No.  72766Q105
13G
  Page _2_ of  4_ Pages

 
1
NAMES OF REPORTING PERSONS
 
Permira IV Managers Limited
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  o
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Guernsey
Number of Shares
Beneficially Owned
by Each Reporting
Person With
5
SOLE VOTING POWER
 
0
6
SHARED VOTING POWER
 
22,107,590*
7
SOLE DISPOSITIVE POWER
 
0
8
Shared Dispositive Power
 
22,107,590*
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
22,107,590*
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
10.3%
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO
 

___________________
 
* These shares are currently held in the form of Series B Preferred Stock, convertible at the Reporting Persons’ option; provided, that 19,296,242 shares may not be converted until the earlier of the expiration or early termination of any waiting period under the HSR Act.
 
The calculation of the foregoing percentage is based on 192,220,472 shares of Common Stock, outstanding as of March 23, 2015 as reported in the Annual Report on Form 10-K for the fiscal year ended December 31, 2014 of Platform Specialty Products Corporation as filed on March 30, 2015.
 

 
 

 

CUSIP No.  72766Q105
13G
  Page _3__ of __4_ Pages

 
1
NAMES OF REPORTING PERSONS
 
Nalozo L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  o
3
SEC USE ONLY
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Cayman Islands
NUMBER OF
 SHARES
 BENEFICIALLY
 OWNED BY EACH
REPORTING
PERSON WITH
5
SOLE VOTING POWER
0
6
SHARED VOTING POWER
22,107,590*
7
SOLE DISPOSITIVE POWER
0
8
SHARED DISPOSITIVE POWER
22,107,590*
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
22,107,590*
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
10.3%
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
PN

___________________
 
* These shares are currently held in the form of Series B Preferred Stock, convertible at the Reporting Persons’ option; provided, that 19,296,242 shares may not be converted until the earlier of the expiration or early termination of any waiting period under the Hart Scot Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”).
 
The calculation of the foregoing percentage is based on 192,220,472 shares of Common Stock (defined below), outstanding as of March 23, 2015 as reported in the Annual Report on Form 10-K for the fiscal year ended December 31, 2014 of Platform Specialty Products Corporation as filed on March 30, 2015.
 

 
 

 

CUSIP No.  72766Q105
13G
  Page _4_ of  4_ Pages

 
1
NAMES OF REPORTING PERSONS
 
Nalozo Cayman GP Ltd.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
(a)  o
(b)  o
3
SEC USE ONLY
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Cayman Islands
Number of Shares
Beneficially Owned
by Each Reporting
Person With
5
SOLE VOTING POWER
 
0
6
SHARED VOTING POWER
 
22,107,590*
7
SOLE DISPOSITIVE POWER
 
0
8
Shared Dispositive Power
 
22,107,590*
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
22,107,590*
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
10.3%
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
OO

___________________
 
* These shares are currently held in the form of Series B Preferred Stock, convertible at the Reporting Persons’ option; provided, that 19,296,242 shares may not be converted until the earlier of the expiration or early termination of any waiting period under the HSR Act.
 
The calculation of the foregoing percentage is based on 192,220,472 shares of Common Stock, outstanding as of March 23, 2015 as reported in the Annual Report on Form 10-K for the fiscal year ended December 31, 2014 of Platform Specialty Products Corporation as filed on March 30, 2015.
 

 
 

 


 Item 1(a).
Name of Issuer.
 
Platform Specialty Products Corporation (the “Company”)
 
 Item 1(b).
Address of Issuer’s Principal Executive Offices.
 
5200 Blue Lagoon Drive, Suite 855
Miami, FL 33126
 
 Item 2(a).
 
 Item 2(b).
 
 Item 2(c). 
 
Name of Person Filing.
 
(i) Permira IV Managers L.P.
c/o Permira IV Managers L.P., Trafalgar Court, Les Banques,
Guernsey, Channel Islands GY1 3QL
Place of Organization: Guernsey, Channel Islands
 
(ii) Permira IV Managers Limited
c/o Permira IV Managers L.P., Trafalgar Court, Les Banques,
Guernsey, Channel Islands GY1 3QL
Place of Organization: Guernsey, Channel Islands
 
(iii) Nalozo L.P.
c/o Permira  Luxembourg S.à r.l. 282,
route de Longwy, L-1940 Luxembourg
Place of Organization: Cayman Islands
 
(iv) Nalozo Cayman GP Ltd.
c/o Permira  Luxembourg S.à r.l. 282,
route de Longwy, L-1940 Luxembourg
Place of Organization: Cayman Islands
 
The foregoing persons are hereinafter sometimes collectively referred to as the “Reporting Persons.
 
The Reporting Persons have entered into a Joint Filing Agreement, dated April 6, 2015, a copy of which is attached as Exhibit A to this statement on Schedule 13G, pursuant to which the Reporting Persons agreed to file this statement on Schedule 13G and any amendments thereto jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.
 
 Item 2(d). 
Title of Class of Securities.
 
Common Stock, par value $0.01 per share (the “Common Stock”)
 
 Item 2(e).
CUSIP Number.
 
72766Q105
 

 
 
 

 

 Item 3. 
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
 
 
Not applicable.
 
 
(a) o  Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
 
(b) o   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
 
(c) o  Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
 
(d) o  Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
 
(e) o  An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
 
(f) o  An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
 
(g) o  A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
 
(h) o  A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
 
(i) o  A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
 
(j) o  A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
 
(k) o  Group, in accordance with §240.13d-1(b)(1)(ii)(K).
 Item 4. 
Ownership.
 
(a) Amount beneficially owned:
See Item 9 of each of the cover pages.
The joint filing of this Schedule 13G is made by the Reporting Persons pursuant to Rule 13d-1(k)(1) and each Reporting Person expressly disclaims any assertion or presumption that it and the other persons on whose behalf this statement is filed constitute a “group.”
 
(b) Percent of class:
See Item 11 of each of the cover pages.
 
(c) Number of Shares as to which the Reporting Person has:
 
 (i) Sole power to vote or direct the vote:  See Item 5 of each of the cover pages.
 (ii) Shared power to vote or direct the vote:  See Item 6 of each of the cover pages.

 
 
 

 

 
 
 (iii) Sole power to dispose or direct the disposition:  See Item 7 of each of the cover pages.
 (iv) Shared power to dispose or direct the disposition:  See Item 8 of each of the cover pages.
 Item 5. 
Ownership of Five Percent or Less of a Class.
 
Not applicable.
 Item 6.
Ownership of More Than Five Percent on Behalf of Another Person.
 
Not applicable.
 Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
 
Not applicable.
 Item 8.
Identification and Classification of Members of the Group.
 
Not applicable.
 Item 9.
Notice of Dissolution of Group.
 
Not applicable.
 Item 10. 
Certification.
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 
 
 

 

 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Dated:  April 6, 2015
 
 
PERMIRA IV MANAGERS L.P.
   
 
By:  Permira Managers Limited, its general partner
   
   
 
/s/ Kees Jager
 
 
Name: Kees Jager
 
Title:   Authorized Signatory
   
   
 
PERMIRA IV MANAGERS LIMITED
   
   
 
/s/ Kees Jager
 
 
Name: Kees Jager
 
Title:   Authorized Signatory
   
 
NALOZO L.P.
 
By:  Nalozo Cayman GP Ltd., its general partner
   
   
 
/s/ John Coyle
 
 
Name: John Coyle
 
Title:   Authorized Signatory
   
   
 
NALOZO CAYMAN GP LTD.
   
   
 
/s/ John Coyle
 
 
Name: John Coyle
 
Title:  Authorized Signatory
 
 

 
 

 

EXHIBIT LIST

Exhibit A
 
Joint Filing Agreement, dated April 6, 2015, by and among Permira IV Managers L.P., Permira IV Managers Limited, Nalozo L.P. and Nalozo Cayman GP Ltd.


EX-99 2 exa.htm EXHIBIT A - JOINT FILING AGREEMENT exa.htm
EXHIBIT A

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned (each, a “Party”) agree to the joint filing on behalf of each of them of a Statement on Schedule 13G with respect to the common stock of Platform Specialty Products Corporation and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filing. The Parties hereby acknowledge and agree that all subsequent amendments to the Statement on Schedule 13G shall be filed on behalf of each of the Parties without the necessity of executing or filing additional joint filing agreements. The Parties hereby acknowledge that each Party shall be responsible for timely filing of such amendments, and for the completeness and accuracy of the information concerning such Party contained therein, but shall not be responsible for the completeness and accuracy of the information concerning any other Party, except to the extent that such Party knows or has reason to believe that such information is inaccurate. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of April 6, 2015.

 
PERMIRA IV MANAGERS L.P.
   
 
By:  Permira Managers Limited, its general partner
   
   
 
/s/ Kees Jager
 
 
Name: Kees Jager
 
Title:   Authorized Signatory
   
   
 
PERMIRA IV MANAGERS LIMITED
   
   
 
/s/ Kees Jager
 
 
Name: Kees Jager
 
Title:   Authorized Signatory
   
   
 
NALOZO L.P.
   
 
By:  Nalozo Cayman GP Ltd., its general partner
   
   
 
/s/ John Coyle
 
 
Name: John Coyle
 
Title:   Authorized Signatory
   
   
 
NALOZO CAYMAN GP LTD.
   
   
 
/s/ John Coyle
 
 
Name: John Coyle
 
Title:  Authorized Signatory